130.63 USD+2.5%Healthcare
About the company
Merck is a research-driven pharmaceutical company with deep roots in oncology, vaccines and infectious disease. Its immunotherapy franchise transformed cancer treatment and the company's finances, while Gardasil protects against HPV-related cancers worldwide. An animal health division adds steady, less cyclical revenue. Merck spends heavily on research and licensing deals to refill its pipeline, a constant necessity in an industry where every blockbuster eventually loses patent protection. The US company traces its history to 1891.
Overall
3.7
Market Cap
—
P/E (ttm)
36.5
Analyst Target
134.04 USD
+2.6%
Data as of 04:26 ·